
199800.KQ does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 199800.KQ and 80,000+ other tickers.
See exactly how 199800.KQ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 199800.KQ and 80,000+ other tickers.
ToolGen Incorporated is a biotechnology enterprise based in South Korea, primarily focused on pioneering advancements in genome editing technology. The company's main endeavor involves engineering CRISPR-Cas9 genetic modification tools specifically designed for editing genes in eukaryotic cells. Furthermore, its operations extend to commercializing its intellectual property, exploring therapeutic applications, and participating in the seed sector. Established in 1999, ToolGen's corporate headquarters are situated in Seoul, South Korea.
No recent news available.